Reeve et al., 1978 - Google Patents
Biological activity of 1 α-hydroxyvitamin D2 in the ratReeve et al., 1978
- Document ID
- 5886746666645540636
- Author
- Reeve L
- Schnoes H
- DeLuca H
- Publication year
- Publication venue
- Archives of Biochemistry and Biophysics
External Links
Snippet
The biological activity of 1α-hydroxyvitamin D 2 has been determined in vitamin D-deficient rats. In the calcification of the rachitic epiphyseal plate, 1α-hydroxyvitamin D 2 is more active than 25-hydroxyvitamin D 3, while it is equally active in stimulating intestinal calcium …
- 241000700159 Rattus 0 title abstract description 24
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DeLuca | Metabolism of vitamin D: current status | |
| DeLuca | History of the discovery of vitamin D and its active metabolites | |
| Sjöden et al. | 1α-Hydroxyvitamin D2 is less toxic than 1α-hydroxyvitamin D3 in the rat | |
| Tanaka et al. | Biological activity of 24, 24-difluoro-25-hydroxyvitamin D3. Effect of blocking of 24-hydroxylation on the functions of vitamin D. | |
| Brown et al. | New active analogues of vitamin D with low calcemic activity. | |
| Henry et al. | Response of chick parathyroid glands to the vitamin D metabolites, 1, 25-dihydroxycholecalciferol and 24, 25-dihydroxycholecalciferol | |
| DeLuca | The kidney as an endocrine organ involved in the function of vitamin D | |
| Holick et al. | Metabolism and biologica. | |
| Norman | Evidence for a new kidney-produced hormone, 1, 25-dihydroxycholecalciferol, the proposed biologically active form of vitamin D | |
| Dr. Bouillon et al. | Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity | |
| DeLUCA | Vitamin D endocrinology | |
| Birge et al. | The role of phosphate in the action of vitamin D on the intestine | |
| Balsan et al. | Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height | |
| Gallagher et al. | Effects of increasing doses of 1α‐hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women | |
| Hughes et al. | Influence of dietary vitamin D3 on the circulating concentration of its active metabolites in the chick and rat | |
| DeLuca | The kidney as an endocrine organ involved in calcium homeostasis | |
| Nishii et al. | History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy) calcitriol (ED-71) | |
| Jones et al. | A dialogue on analogues newer vitamin-D drugs for use in bone disease, psoriasis, and cancer | |
| Holick et al. | Biological activity of 1α-hydroxyvitamin D3 in the rat | |
| Sjöden et al. | Antirachitic activity of 1α-hydroxyergocalciferol and 1α-hydroxycholecalciferol in rats | |
| Finch et al. | Differential effects of 1, 25-(OH) 2D3 and 22-oxacalcitriol on phosphate and calcium metabolism | |
| Reeve et al. | Biological activity of 1 α-hydroxyvitamin D2 in the rat | |
| DeLuca | Osteoporosis and the metabolites of vitamin D | |
| Sinha et al. | Evidence for a defect in the formation of 1α, 25-dihydroxyvitamin D in pseudohypoparathyroidism | |
| Raisz | 2 Direct effects of vitamin D and its metabolites on skeletal tissue |